SARS-CoV-2 Spike Glycoprotein (S Protein RBD Subunit) AAV Virus

The SARS-CoV-2 transmembrane spike glycoprotein (S Protein) forms homotrimers that protrude from the Coronavirus surface and mediates the entry of Coronavirus into host cells. The RBD or receptor binding domain of the S1 subunit mediates binding to the host cell by recognizing host cell receptors, one of which has recently been identified as ACE2
Expression products available for SARS-CoV-2 S Protein RBD Subunit:

• S Protein RBD Lentiviral Vector


• S Protein RBD Lentivirus


• S Protein RBD AAV Vector


• S Protein RBD AAV


• S Protein RBD Adenovirus


• S Protein RBD ORF Vector


• S Protein RBD Protein Vector


• S Protein RBD Recombinant Protein

We will provide qPCR based titer evaluation for standard AAV virus orders as determination of successful packaging. In addition, if your virus has a GFP or RFP reporter (with no induction required for expression), we will also perform viral infectivity testing in our standard evaluation cell line - HEK293T. An image of the infectivity results will be provided on the CoA. Since infectivity is serotype dependent, and HEK293T cells do not infect well with Serotypes 4, 5 and 6, an infectivity test will not be provided for these serotypes. In such cases, qPCR titer evaluation will be used as the final parameter to determine successful viral packaging.

>10⁹ GC/ml

Virus